{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T05:21:04Z","timestamp":1764480064398,"version":"3.46.0"},"reference-count":52,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["445006\/2014-5"],"award-info":[{"award-number":["445006\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Evandro Chagas Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Background\/Objectives: Serological and molecular screening for Hepatitis B virus (HBV) has been essential in reducing the risk of transfusion-transmitted infection, particularly in regions of high endemicity. This retrospective study aimed to analyze the epidemiological profile and laboratory outcomes of 259 blood donors deemed ineligible after initial reactive or inconclusive screening for HBV markers. Methods: Donors were summoned for revaluation at the HEMOPA Foundation, in Bel\u00e9m, Par\u00e1, between February 2015 and July 2016. Demographic data, risk factors, and results for HBsAg, anti-HBc, anti-HBs, and HBV DNA obtained at the donation and return time points were collected. Results: The mean age was 37 \u00b1 11.25 years, with a predominance of males (56.8%) and first-time donors (76%). At the return time point, 63.7% presented a profile indicative of resolved HBV infection and 3.5% of active infection, 6.6% were susceptible to HBV infection, and 1.9% presented vaccine-induced HBV immunity. Cases of Occult Hepatitis B Infection (OBI, 0.4%) and Window Period (WP, 0.4%) were also identified. Conclusions: The findings reveal a high prevalence of resolved HBV infection among ineligible donors, particularly first-time donors, and reinforce the importance of combined serological and molecular screening, as well as the need for vaccination and health education strategies for at-risk populations. As a public blood bank located in the Amazon region, we highlight that local epidemiological specificities must be considered in the formulation of public health policies that are sensitive to the regional context.<\/jats:p>","DOI":"10.3390\/idr17060145","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T09:56:02Z","timestamp":1764323762000},"page":"145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological Profile and Diagnostic Outcomes of Blood Donors Following Hepatitis B Screening at the Largest Blood Bank in the State of Par\u00e1, Brazil"],"prefix":"10.3390","volume":"17","author":[{"given":"N\u00fabia Caroline Costa de","family":"Almeida","sequence":"first","affiliation":[{"name":"Foundation Center for Hemotherapy and Hematology of Par\u00e1, Nucleic Acid Test (NAT) Department, Bel\u00e9m 66033-000, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Monteiro Rodrigues","family":"Coelho","sequence":"additional","affiliation":[{"name":"Evandro Chagas Institute, Health Ministry of Brazil, Ananindeua 67030-000, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Fonseca","family":"Barroso","sequence":"additional","affiliation":[{"name":"Foundation Center for Hemotherapy and Hematology of Par\u00e1, Nucleic Acid Test (NAT) Department, Bel\u00e9m 66033-000, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo de Melo","family":"Amaral","sequence":"additional","affiliation":[{"name":"Foundation Center for Hemotherapy and Hematology of Par\u00e1, Nucleic Acid Test (NAT) Department, Bel\u00e9m 66033-000, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Bezerra Hermes de","family":"Castro","sequence":"additional","affiliation":[{"name":"Foundation Center for Hemotherapy and Hematology of Par\u00e1, Nucleic Acid Test (NAT) Department, Bel\u00e9m 66033-000, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia Martins","family":"Lamar\u00e3o","sequence":"additional","affiliation":[{"name":"Foundation Center for Hemotherapy and Hematology of Par\u00e1, Nucleic Acid Test (NAT) Department, Bel\u00e9m 66033-000, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-7906","authenticated-orcid":false,"given":"Jacqueline Cortinhas","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Institute of Biological Sciences, Federal University of Par\u00e1, Bel\u00e9m 66075-110, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-7640","authenticated-orcid":false,"given":"Lucimar Di Paula dos Santos","family":"Madeira","sequence":"additional","affiliation":[{"name":"Institute of Biological Sciences, Federal University of Par\u00e1, Bel\u00e9m 66075-110, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-4109","authenticated-orcid":false,"given":"Igor","family":"Brasil-Costa","sequence":"additional","affiliation":[{"name":"Evandro Chagas Institute, Health Ministry of Brazil, Ananindeua 67030-000, PA, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations\u2014United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm. Rep."},{"key":"ref_2","unstructured":"International Committee on Taxonomy of Viruses (ICTV) (2025, July 01). Virus Taxonomy: 2024 Release. Available online: https:\/\/ictv.global\/taxonomy."},{"key":"ref_3","unstructured":"World Health Organization (WHO) (2025, July 01). Hepatitis B. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_4","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente, Departamento de HIV\/Aids, Tuberculose, and Hepatites Virais e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis (2025, July 01). Boletim Epidemiol\u00f3gico\u2014Hepatites Virais 2023, Available online: https:\/\/www.gov.br\/aids\/pt-br\/central-de-conteudo\/boletins-epidemiologicos\/2023\/hepatites-virais\/boletim-epidemiologico-hepatites-virais-_-2023.pdf\/view."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e11283","DOI":"10.25248\/reaenf.e11283.2022","article-title":"Motivos de inaptid\u00e3o de candidatos \u00e0 doa\u00e7\u00e3o de sangue do Brasil: Uma revis\u00e3o narrativa","volume":"20","author":"Winter","year":"2022","journal-title":"Rev. Eletr\u00f4n. Acervo Enferm."},{"key":"ref_6","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade (2025, July 01). Portaria de Consolida\u00e7\u00e3o N\u00b0.5, de 28 de Setembro de 2017, Consolida\u00e7\u00e3o das Normas Sobre as A\u00e7\u00f5es e os Servi\u00e7os de Sa\u00fade do Sistema \u00danico de Sa\u00fade, Available online: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/saude-de-a-a-z\/s\/saude-da-pessoa-com-deficiencia\/legislacao\/portaria-de-consolidacao-no-05-de-28-de-setembro-de-2017.pdf\/view."},{"key":"ref_7","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, and Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Doen\u00e7as Sexualmente Transmiss\u00edveis, Aids e Hepatites Virais (2025, July 01). Manual T\u00e9cnico Para o Diagn\u00f3stico das Hepatites Virais, Available online: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_tecnico_diagnostico_hepatites_virais.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e38210918337","DOI":"10.33448\/rsd-v10i9.18337","article-title":"Preval\u00eancia da reatividade ao anti-HBc total (IgM, IgG) em candidatos \u00e0 doa\u00e7\u00e3o de sangue, em uma regi\u00e3o do nordeste do Brasil","volume":"10","author":"Teles","year":"2021","journal-title":"Res. Soc. Dev."},{"key":"ref_9","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade, Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) (2025, July 01). Produ\u00e7\u00e3o Hemoter\u00e1pica no Brasil, Available online: https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/noticias-anvisa\/2022\/anvisa-divulga-9o-boletim-de-producao-hemoterapica."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Corr\u00eaa, A.S.M., Lamar\u00e3o, L.M., Vieira, P.C.M., Castro, R.B.H., Almeida, N.C.C., Castro, J.A.A., Lima, M.S.M., Palmeira, M.K., Meireles, A.L.L.P., and Burbano, R.R. (2018). Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208414"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Mart\u00ednez, F., Z\u00fa\u00f1iga-Maga\u00f1a, A.G., Barrera-de-Le\u00f3n, J.C., Magan\u00e3-Duarte, R., and Ortu\u00f1o-Sahag\u00fan, D. (2021). Retrospective study of the seroprevalence of HIV, HCV, and HBV in blood donors at a blood bank of western Mexico. Pathogens, 10.","DOI":"10.3390\/pathogens10070878"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Serrano-Delgado, V.M., Valdez-Mart\u00ednez, E., and M\u00e1rquez-Gonz\u00e1lez, H. (2022). Donor notification of permanent deferral: A qualitative study on the perceptions and practices of notifier and blood donor in Mexico. BMC Health Serv. Res., 22.","DOI":"10.1186\/s12913-022-08103-1"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S821","DOI":"10.1016\/j.htct.2023.09.1482","article-title":"Estudo comparativo entre os m\u00e9todos sorol\u00f3gico e molecular na investiga\u00e7\u00e3o da infec\u00e7\u00e3o pelo HBV e HCV na triagem de doadores de sangue do Instituto de Hematologia e Hemoterapia do Amap\u00e1","volume":"45","author":"Lopes","year":"2023","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_14","first-page":"1","article-title":"Preval\u00eancia e associa\u00e7\u00e3o da sorologia reagente para HIV, s\u00edfilis, hepatites B e C em doadores de sangue","volume":"10","author":"Santos","year":"2024","journal-title":"Rev. Cient. Esc. Estadual Sa\u00fade P\u00fablica Goi\u00e1s \u201cC\u00e2ndido Santiago\u201d"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jaldo, M.M., Joffe, M.W.Y., and Zemedkun, E.S. (2025). Prevalence of hepatitis B virus and associated factors among blood donors in Hossana blood bank catchment area, Southern Ethiopia. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10550-0"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mohamud, A.K., Inchon, P., Suwannaporn, S., Prasert, K., and Dirie, N.I. (2024). Assessment of prevalence and risk factors associated with Hepatitis B virus infection among blood donors in Mogadishu, Somalia. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-18136-2"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.1016\/j.htct.2022.09.628","article-title":"Fatores associados \u00e0 fideliza\u00e7\u00e3o de doadores de sangue: Um estudo de caso-controle","volume":"44","author":"Pedrosa","year":"2022","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S779","DOI":"10.1016\/j.htct.2024.09.1314","article-title":"Perfil epidemiol\u00f3gico dos doadores de sangue do Vita Hemoterapia da Bahia","volume":"46","author":"Jesus","year":"2024","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2020.07.030","article-title":"Seroprevalence of hepatitis B and hepatitis C among blood donors in Sierra Leone: A multi-year retrospective study","volume":"99","author":"Tognon","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Grubyte, S., Urboniene, J., Nedzinskiene, L., Jelinskaite, A., Zagminas, K., Ambrozaitis, A., and Jancoriene, L. (2021). Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence\/window-period model study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0246704"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Nouanthong, P., Hefele, L., Keokhamphue, J., Sorrasin, V., Khounvisith, V., Souksakhone, C., Jutavijittum, P., Muller, C.P., Black, A.P., and H\u00fcbschen, J.M. (2021). Analyses of blood donor samples from eight provinces in Lao PDR suggest considerable variation concerning HBV exposure and carriage. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0259814"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/21645515.2019.1666612","article-title":"Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results","volume":"16","author":"Ren","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_23","first-page":"e202200942","article-title":"Soropreval\u00eancia e fatores de risco das hepatites A, B e C em uma unidade de refer\u00eancia de doen\u00e7as infecciosas e parasit\u00e1rias especiais, em Bel\u00e9m, estado do Par\u00e1, Brasil","volume":"13","author":"Alves","year":"2022","journal-title":"Rev. Pan-Amaz. Sa\u00fade"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e23010915334","DOI":"10.33448\/rsd-v10i9.15334","article-title":"An\u00e1lise da cobertura vacinal e casos de hepatite B no Estado do Par\u00e1","volume":"10","author":"Moraes","year":"2021","journal-title":"Res. Soc. Dev."},{"key":"ref_25","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica (2024). Boletim Epidemiol\u00f3gico das Hepatites Virais 2024, Minist\u00e9rio da Sa\u00fade."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Li, M., Zu, J., Shen, M., Zhuang, G., Chen, S., Wang, F., Zheng, H., and Zhang, G. (2021). Evaluating the independent influence of sexual transmission on HBV infection in China: A modeling study. BMC Public Health, 21.","DOI":"10.1186\/s12889-021-10408-5"},{"key":"ref_27","first-page":"88","article-title":"Evaluation of awareness of beauty employees about hepatitis B virus infection","volume":"24","author":"Turgambayeva","year":"2022","journal-title":"Sci. Healthc."},{"key":"ref_28","first-page":"254","article-title":"Hepatitis B, C in Dentistry","volume":"4","author":"Sodikova","year":"2024","journal-title":"Multidiscip. J. Sci. Technol."},{"key":"ref_29","first-page":"107","article-title":"Infec\u00e7\u00e3o pelo v\u00edrus da hepatite B: Situa\u00e7\u00e3o epidemiol\u00f3gica de usu\u00e1rios de drogas il\u00edcitas em munic\u00edpio \u00e0 margem de rios na Amaz\u00f4nia brasileira","volume":"Volume 1","author":"Salgado","year":"2018","journal-title":"Patologia das Doen\u00e7as"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jmv.21464","article-title":"Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users","volume":"81","author":"Ferreira","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00705-016-3060-z","article-title":"Characterization of hepatitis B virus infection in illicit drug users in the Maraj\u00f3 Archipelago, northern Brazil","volume":"162","author":"Andrade","year":"2017","journal-title":"Arch. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1007644","article-title":"Nucleic acid testing to detect HBV infection in blood donors","volume":"364","author":"Stramer","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Madihi, S., Charoute, H., Boukaira, S., Bouafi, H., Baha, W., Zyad, A., and Benani, A. (2024). Virological characterization of hepatitis B virus infection in Morocco: A ten-years study (2014\u20132023). Diagn. Microbiol. Infect. Dis., 110.","DOI":"10.1016\/j.diagmicrobio.2024.116502"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14295\/vittalle.v33i2.12207","article-title":"An\u00e1lise temporal de descarte de bolsas de sangue por sorologia positiva no Hemon\u00facleo de Reden\u00e7\u00e3o\u2013HENRE\u2013(Par\u00e1) de 2010 a 2017","volume":"33","author":"Rodrigues","year":"2021","journal-title":"VITTALLE-Rev. Ci\u00eanc. Sa\u00fade"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S935","DOI":"10.1016\/j.htct.2023.09.1681","article-title":"Inaptid\u00e3o na Triagem Sorol\u00f3gica: Uma An\u00e1lise Comparativa na Popula\u00e7\u00e3o de Doadores em Sergipe entre 2018 a 2022, com Destaque para Positividade de S\u00edfilis","volume":"45","author":"Oliveira","year":"2023","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S676","DOI":"10.1016\/j.htct.2023.09.1231","article-title":"An\u00e1lise das Inaptid\u00f5es Sorol\u00f3gicas por Tipo de Doa\u00e7\u00e3o no Per\u00edodo de 2021 \u00e0 2023 em um Servi\u00e7o de Hemoterapia da Serra Ga\u00facha","volume":"45","author":"Souza","year":"2023","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gemechu, G., Abagez, W.E., Alemayehu, D.H., Tesfaye, A., Tadesse, D., Kinfu, A., Mihret, A., and Mulu, A. (2022). Occult hepatitis B virus infection among blood donors in the capital city of Addis Ababa, Ethiopia: Implications for blood transfusion safety. Front. Gastroenterol., 1.","DOI":"10.3389\/fgstr.2022.887260"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.2147\/IDR.S357819","article-title":"Updated seroprevalence of hepatitis B surface antigen and anti-hepatitis core antibody among blood donors in Yemen","volume":"15","author":"Alzubieiry","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5073171","DOI":"10.1155\/2022\/5073171","article-title":"Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among blood donors from Bahir Dar, Ethiopia","volume":"2022","author":"Assefa","year":"2022","journal-title":"Adv. Public Health"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/trf.16344","article-title":"Occult and active hepatitis B virus detection in donated blood in Sao Paulo, Brazil","volume":"61","author":"Nishiya","year":"2021","journal-title":"Transfusion"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Tung, T.T., Schimd, J., Nghia, V.X., Cao, L.C., Linh, L.T.K., Rungsung, I., Sy, B.T., My, T.N., The, N.T., and Hoan, N.X. (2022). Low risk of occult hepatitis B infection among Vietnamese blood donors. Pathogens, 11.","DOI":"10.3390\/pathogens11121524"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3343\/alm.2019.39.1.81","article-title":"Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results from a Five-Year Retrospective Study of HBV Seromarkers","volume":"39","author":"Alzahrani","year":"2019","journal-title":"Ann. Lab. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11901-020-00522-0","article-title":"Hepatitis B core antibody: Role in clinical practice in 2020","volume":"19","author":"Gish","year":"2020","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e0554","DOI":"10.1097\/HC9.0000000000000554","article-title":"A Need for Confirmatory Testing of Isolated HBcAb-Positive Results in Screening Programs","volume":"8","author":"Fu","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2206774","DOI":"10.1080\/21645515.2023.2206774","article-title":"Prevalence of Antibody to Hepatitis B Surface Antigen among Qualified Blood Donors in Nanjing, China","volume":"19","author":"Zhou","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_46","first-page":"35","article-title":"Detection of Anti-HBc (Total) and HBV-DNA in Hepatitis B Virus Surface Antigen Negative Blood Donors","volume":"7","author":"Karim","year":"2025","journal-title":"Eur. J. Med. Health Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/vox.12675","article-title":"False Positive Viral Marker Results in Blood Donors and Their Unintended Consequences","volume":"113","author":"Kiely","year":"2018","journal-title":"Vox Sang."},{"key":"ref_48","first-page":"9928098","article-title":"An Interesting Case of Isolated False-Reactive Hepatitis B Surface Antigen","volume":"2021","author":"Costa","year":"2021","journal-title":"Case Rep. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wu, D., Hu, Y., Wang, M., Wu, Y., Dong, J., Liu, J., and Hu, W. (2024). Establishing a screening strategy for non-discriminatory reactive blood donors by constructing a predictive model of hepatitis B virus infection status from a single blood center in China. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1366431"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00430-010-0160-3","article-title":"The underlying mechanisms for the \u201cisolated positivity for the hepatitis B surface antigen (HBsAg)\u201d serological profile","volume":"200","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.7754\/Clin.Lab.2024.240337","article-title":"Application study of neutralization confirmatory testing for low positive hepatitis B surface antigen","volume":"70","author":"Han","year":"2024","journal-title":"Clin. Lab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.22207\/JPAM.18.1.38","article-title":"Role of HBsAg neutralisation test in low positive and indeterminate HBsAg results by electrochemiluminescence","volume":"18","author":"Madiyal","year":"2024","journal-title":"J. Pure Appl. Microbiol."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/6\/145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T05:19:02Z","timestamp":1764479942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/6\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["idr17060145"],"URL":"https:\/\/doi.org\/10.3390\/idr17060145","relation":{},"ISSN":["2036-7449"],"issn-type":[{"type":"electronic","value":"2036-7449"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}